drugset / Trial / NCT02573844

Pain Relief In Irritable Bowel Syndrome

NCT02573844 ↗

Phase 4 Completed 30 enrolled Geophyt S.r.l.s.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether Proklama is effective in significative reduction of pain, other symptoms IBS's related, and improves quality of life concerning IBS disease.

Timeline

Start
2015-01
Primary completion
2017-10
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Proklama Unknown 1 unknown —